DIALYSIS · Loading…
DIALYSIS · CCN 332761
DaVita Melrose Dialysis
BRONX, NY 10455
DialysisProfitDaVita
$5.5M
TOTAL REVENUE
5.0%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2024)
- Net patient revenue
- $5.5M
- Total costs
- $5.2M
- Operating income (rev − costs)
- $277K
- Operating margin
- 5.0%
- Total charges
- $5.3M
- Total treatments
- 14,688
- Dialysis stations
- 24
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
13 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 0.64 | 38 | — |
Fistula Rate DFC_FISTULA_RATE | 71.7 | 118 | — |
Five Star Rating DFC_FIVE_STAR | 4 | — | — |
First Year Standardized Kidney Transplant Waitlist Ratio DFC_FYSWR | 0.57 | 89 | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 0 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 149.6 | 86 | — |
Standard Infection Ratio (SIR) DFC_INFECTION_RATIO | 0 | — | — |
Percentage of Adult Patients with Long Term Catheter in Use DFC_LONG_CATHETER | 12 | 118 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 12.4 | 349 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 20.3 | 102 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 30.4 | 87 | — |
Standardized ED Visits Ratio DFC_SEDR | 1.02 | 22 | — |
Patient Transfusion Rate DFC_TRANSFUSION_RATE | 26.5 | 18 | — |